During the past decade, Southern Oncology Hematology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Oncology Hematology Associates" #1 collaborator was "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Southern Oncology Hematology Associates" are "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Southern Oncology Hematology Associates" in a lesser frequency.

The vast majority of trials in "Southern Oncology Hematology Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Southern Oncology Hematology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Southern Oncology Hematology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Oncology Hematology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".